Supporting healthcare innovation helps ensure that there is motivation and incentive into the treatment of less common ailments such as rare diseases. People with these diseases should not be left behind.
Investing in digital solutions could dramatically improve productivity and efficiency, with benefits in both patient outcomes and cost.
We need to discuss how we can move forward, address concerns related to intellectual property protections, and support the government’s agenda of ongoing national healthcare reform.
“By not considering potential variables that contribute to transgressions or non-compliance, it punishes an already vulnerable community for something that may not have been avoidable, of their fault or ability to control. It is a recipe to drive people to the brink.”
There is cause for concern as an insufficient allocation could result in shortages of essential drugs.
Chief Executive, Galen Centre